D2R awards $7.3 million to Advance Research in Genomic-Based RNA Therapeutics
Montreal – September 17, 2024Ìý º«¹úÂãÎè’s D2R initiative is proud to announce the 23 recipients of its inaugural funding programs, Foundational Projects and Research in Motion. With a total investment of $7.3 million, these awards mark a significant milestone in advancing the field of genomic-based RNA therapeutics.